Drug Screening

Lowest Prices Guaranteed	Length	Publisher	Published Date	SKU
from $4,950	202 Pages	Global Industry Analysts	October, 2022	GJOB17425247

Lowest Prices Guaranteed
Price	from $4,950
Length	202 Pages
Publisher	Global Industry Analysts
Published Date	October, 2022
SKU	GJOB17425247

Drug Screening

Global Drug Screening Market to Reach $17.4 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Drug Screening estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$17.4 Billion by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 14% CAGR and reach US$9.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 20.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 15.8% CAGR

The Drug Screening market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3 Billion by the year 2027 trailing a CAGR of 15.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.3% and 14.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Select Competitors (Total 53 Featured) -

Alere, Inc.
Alfa Scientific Designs, Inc.
Dragerwerk AG & Co. KGaA
F. Hoffmann-La Roche AG
Laboratory Corporation of America Holdings (LabCorp)
Lifeloc Technologies, Inc.
Mpd, Inc.
Omega Laboratories, Inc.
OraSure Technologies, Inc.
Premier Biotech, Inc.
Psychemedics Corporation
Quest Diagnostics, Inc.
Shimadzu Corporation
Siemens Healthineers
Thermo Fisher Scientific, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW: Influencer Market Insights; Drug Screening – Global Key Competitors Percentage Market Share in 2022 (E); Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E); Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE: TABLE 1: World Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 2: World Historic Review for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 3: World 15-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027; TABLE 4: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 5: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 6: World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 10: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 12: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 13: World Recent Past, Current & Future Analysis for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 14: World Historic Review for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 15: World 15-Year Perspective for Breath by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 16: World Recent Past, Current & Future Analysis for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 17: World Historic Review for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 18: World 15-Year Perspective for Oral Fluid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 19: World Recent Past, Current & Future Analysis for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 20: World Historic Review for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 21: World 15-Year Perspective for Hair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 22: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 23: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 24: World 15-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027; TABLE 25: World Drug Screening Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS: UNITED STATES; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E); TABLE 26: USA Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 27: USA Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 28: USA 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 29: USA Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 30: USA Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 31: USA 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; CANADA; TABLE 32: Canada Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 33: Canada Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 34: Canada 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 35: Canada Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 36: Canada Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 37: Canada 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; JAPAN; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E); TABLE 38: Japan Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 39: Japan Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 40: Japan 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 41: Japan Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 42: Japan Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 43: Japan 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; CHINA; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E); TABLE 44: China Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 45: China Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 46: China 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 47: China Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 48: China Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 49: China 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; EUROPE; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E); TABLE 50: Europe Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR; TABLE 51: Europe Historic Review for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 52: Europe 15-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027; TABLE 53: Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 54: Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 55: Europe 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 56: Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 57: Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 58: Europe 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; FRANCE; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E); TABLE 59: France Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 60: France Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 61: France 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 62: France Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 63: France Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 64: France 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; GERMANY; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E); TABLE 65: Germany Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 66: Germany Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 67: Germany 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 68: Germany Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 69: Germany Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 70: Germany 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; ITALY; TABLE 71: Italy Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 72: Italy Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 73: Italy 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 74: Italy Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 75: Italy Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 76: Italy 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; UNITED KINGDOM; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E); TABLE 77: UK Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 78: UK Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 79: UK 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 80: UK Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 81: UK Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 82: UK 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; REST OF EUROPE; TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 84: Rest of Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 85: Rest of Europe 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 87: Rest of Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 88: Rest of Europe 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; ASIA-PACIFIC; Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E); TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 90: Asia-Pacific Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 91: Asia-Pacific 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 93: Asia-Pacific Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 94: Asia-Pacific 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027; REST OF WORLD; TABLE 95: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 96: Rest of World Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 97: Rest of World 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027; TABLE 98: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR; TABLE 99: Rest of World Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR; TABLE 100: Rest of World 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
IV. COMPETITION